Molecular links between cellular mortality and immortality (Review)

Anticancer Research

Volumn 16, Issue 5 A, 1996, Pages 2901-2910

  Derventzi, Anastassia ^a,b   Rattan, Suresh I S ^b   Gonos, Efstathios S ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Ageing; Cancer; Cyclin dependent kinase inhibitors; Oncogenes; Senescence; Tumour suppressor genes

Indexed keywords

ARTICLE; BIOCHEMISTRY; CELL AGING; CELL DEATH; CELL DIVISION; CELL IMMORTALIZATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

CELL AGING; CELL DEATH; CELL DIVISION; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; HOMEOSTASIS;

EID: 0029909168     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Gonos ES, Powell AJ, Ikram Z, Cline M and Jat PS: A molecular genetic approach towards senescence and immortalisation. In: Current Perspectives on Molecular and Cellular Oncology. JAI Press Ltd., 1992, pp163-195.
2. Hayflick L: Ageing under glass. Mutation Res 256: 69-80, 1991.
3. Holliday R: Understanding Ageing. Cambridge University Press, 1995.
4. Grana X and Reddy EP: Cell cycle control in mammalian cells: role of cyclins CDKs, growth suppressor genes and CKIs. Oncogene 11: 211-219, 1995.
5. Ellis RE: Negative regulators of programmed cell death. Curr Opin Genet Dev 2, 635-641, 1992.
6. Huffman B and Liebermann DA: Molecular controls of apoptosis: differentiation/growth arrest primary responce genes, protooncogenes and tumour suppressor genes as positive and negative modulators. Oncogene 9: 1807-1812, 1994.
7. Sherwood SW, Rush D, Ellsworth JL and Schimke RT: Defining cellular senescence in IMR-90 cells: A flow cytometric analysis. Proc Natl Acad Sci U.S.A. 85: 9086-9090, 1988.
8. Gonos ES, Powell AP and Jat PS: Human and rodent fibroblasts: model systems for studying senescence and immortalisation. Int J Oncol 1: 209-213, 1992.
9. Derventzi A and Rattan SIS: Homeostatic imballance during cellular ageing: altered responsiveness. Mutat Res 256: 191-202, 1991.
10. Derventzi A, Rattan SIS and Clark BFC: Senescent human fibroblasts are more sensitive to the effects of a phorbol ester on macromolecular synthesis and growth characteristics. Biochem Inter 27: 903-911, 1992.
11. Derventzi A, Rattan SIS and Clark BFC: Phorhol ester PMA stimulates protein synthesis and increases the levels of active elongation factors EF-1a and EF-2 in ageing human fibrohlasts. Mech Ageing Dev 69: 193-205, 1993.
12. De Tata V, Ptasznik A and Cristofalo VJ: Effect of the tumour promoter phorbol-12-myristate-13-acetate (PMA) on proliferation of young and senescent WI-38 human diploid fibroblasts. Exp Cell Res 205: 261-269, 1993.
13. Hart RW and Turturro A: Overview of cancer and ageing: a mechanistic perspective. Exp Gerontol 27: 567-574, 1992.
14. Kaufman WK and Kaufman DG: Cell cycle control. DNA repair and intitiation of carcinogenesis, FASEB J 7: 1188-1191, 1994.
15. Fesus L, Daview PJA and Piacentini M: Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol 56: 170-177, 1991.
16. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-rnyc protein. Cell 69: 119-128, 1992.
17. Yanagihara K and Tsumuraya M: TGF-b1 induces apoptotic cell death in cultured human gastric carcinoma cells. Cancer Res 52: 4042-4045, 1992.
18. 1 and S phases of the cell cycle without growth arrest and stabilisation of wild type p53. Mol Cell Biol 14: 4183-4192, 1994.
19. 1 induced apoptosis of myeloid leukemia cells. Mol Cell Biol 14: 2352-2360, 1994.
20. Kiefer MC, Brauer MJ, Powers VC, Wu JJ, Umansky SR, Tomei LD and Barr PJ: Modulation of apoptosis by the widely distrubed bcl2 homologue bax. Nature 374: 736-738, 1995.
21. Yonish-Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
22. Chiou SK, Rao L and White E: bcl-2 blocks p53 dependent apoptosis. Mol Cell Biol 14: 2556-2563, 1994.
23. Fisher D: Apoptosis in cancer therapy: crossing the threshold. Cell 78: 539-542, 1994.
24. Liebermann DA, Hoffman B and Steinman RA: Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199-210, 1995.
25. Wang E: Senescent human fibrohlasts resist programmed cell death and failure to suppress bcl-2 is involved. Cancer Res 55: 2284-2292, 1995.
26. Tice RR and Setlow RB: DNA repair and replication in ageing organisms and cells. In: Handbook of the biology of ageing. (Eds. Finch, C.E. and Schneider. E.L.), New York, Van Nostrand Reinhold. Second ed., 1985, pp173-224.
27. Rattan SIS: DNA damage and repair during cellular ageing. Int Rev Cytol 116: 47-88, 1989.
28. Harley CB: Telomere loss: mitotic clock or genetic time bomb? Mutat Res 256: 271-282, 1991.
29. Macieira-Coelho A: Chromatin reorganization during senescence of proliferating cells. Mutat Res 256: 81-104, 1991.
30. Weirich-Schwaiger H, Weirich HG, Gruber B, Schweiger M and Hirsch-Kauffmann M: Correlation between senescence and DNA repair in the cells from young and old individuals and in premature ageing syndromes. Mutat Res 316: 37-48, 1994.
31. Catania J and Fairweather DS: DNA methylation and cellular ageing. Mutat Res 256: 283-293, 1991.
32. Sugawara O, Oshimura M, Koi M, Annab LA and Barrett JC: Induction of cellular senescence in immortalised cells by human chromosome 1. Science 247: 707-710, 1990.
33. Hensler PJ, Annab LA, Barret JC and Pereira-Smith OM: A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol 14: 2291-2297, 1994.
34. Klein CB, Conway K, Wang XW, Bhamra RK, Lin X, Cohen MD, Annab J, Barrett JC and Costa M: Senescence of nickeltransformed cells by an X chromosome: possible epigenetic control. Science 251: 796-799, 1991.
35. Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR and Pereira-Smith OM: Genetic analysis of indefinite division in humun cells: evidence for a senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci U.S.A. 88: 5635-5639, 1991.
36. Hubbard-Smith K, Patsalis P, Pardinas JR, Jha KK, Henderson AS and Ozer HL: Altered chromosome 6 in immortal human fibroblasts. Mol Cell Biol 12: 2273-2281, 1992.
37. Solomon E, Borrow J and Goddard AD: Chromosome aberrations and cancer. Science 254: 1153-1160, 1991.
38. Rimessi P, Gualandi F, Moreli C, Trabanelli C, Wu Q, Possati L, Montesi M, Barrel JC and Barbanti-Brodano G: Transfer of human chromosome 3 to an ovarian carcinoma cell line identifies three regions on 3p involved in ovarian cancer. Oncogene 9: 3467-3474, 1994.
39. Ning Y, Shay JW, Lovell M, Taylor L, Ledbetter DH and Pereira-Smith OM: Tumor suppression by chromosome 11 is not due to cellular senescence. Exp Cell Res 192: 220-226, 1991.
40. Mariotti S, Barbesino G, Caturegli P, Bartalena L, Sansoni P, Fagnoni F, Monti D, Fagiolo U, Francesci C and Pinchera A: Complex alteration of thyroid function in healthy centenerians. J Clin Endocrinol Metabol 177: 1130-1134, 1993.
41. Schachter F, Cohen D and Kirkwood T: Prospects for the genetics of human longevity. Human Genet 91: 519-526, 1993.
42. Schachtcr FL, Faure-Delanef L, Guenot F, Rouger H, Frouguel P. Lesueur-Ginot L and Cohen D: Genetic association with human longevity at the APO E and ACE loci. Nature Genet 6: 29-35, 1994.
43. Shepherd JCW, Waildorf U, Hug P and Ghering WJ: Fruit flies with additional expression of the elongation factor EF-1a live longer. Proc Natl Acad Sci U.S.A. 86: 7520-7521, 1989.
44. Orr WC and Sohal RS: Extension of lifespan by overexpression of Superoxide dismutase and catalase in Drosophila melanogasler. Science 26: 1128-1130, 1994.
45. Murano S, Thweatt R, Shmookler-Reis RJ, Jones RA, Moerman EJ and Goldstein S: Diverse gene sequences are overexpressed in Werner syndrome fibroblasts undergoing premature replicative senescence. Mol Cell Biol 11: 3905-3914, 1991.
46. Goate A, Chartier-Harlin MC, Mulloen M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, Mant R, Newton P, Rooke K, Roques P, Talbot C, Pericak-Vance M, Roses A, Williamson R, Rossor M, Owen M and Hardy J: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349: 704-706, 1991.
47. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, GAskell PC Small GW, Roses AD, Haines JL and Pericak-Vance MA: Gene dose of apolipoprotein E type 4 allcle and the risk of Alzeimer's disease in late onset families. Science 261: 921-924,1993.
48. Nuell MJ, Stewart DA, Walker L, Friedman V, Wood CM, Owens GA, Smith JR, Schneider EL, Dell'Orco R, Lumpkin CK, Danner DB and Mc Clung JK: Prohibitin an evolutionary conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol Cell Biol 11: 1372-1381, 1991.
49. Maier JAM, Voulalas P, Roeder D and Maciag T: Extension of the life span of human endothelial cells by a interleukin-1a antisence oligomer. Science 249: 1570-1574, 1990.
50. Monti D, Grassilli E, Troiano L, CAssarizza A, Salvioli S, Barbieri D, Agnesini C, Bettuzzi S, Inglctti MC, Corti A and Franceschi C: Senescence, immortalisation and apoptosis: an intriguing relationship. Ann New York Acad Sci 673: 70-82,1992.
51. Cristofalo VJ and Pignolo RJ: Replicative senescence of human fibroblast-like cells in culture. Physiol Rev 73: 617-640, 1993.
52. Campos L, Sahido O, Rouault JP and Guyotat D: Effects of bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 84: 595-600, 1994.
53. Fagiolo U, Cassarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C and Paganelli R: Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 23: 2375-2375, 1993.
54. Satoh Y, KAshimura M, Kaneko S, Karasaki Y, Higashi K and Gotoh S: Cloning of cDNAs with possible association with senescence and immortalisation of human cells. Mutat Res 316: 25-36, 1994.
55. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211: 90-98, 1994.
56. Tahara H, Sato E, Noda A and Ide T: Increase in expression level of p21(sdi-1/cip-1/waf-1) with increasing division age in both normal and SV-40-transformed human fibroblasts. Oncogene 10: 835-840, 1995.
57. Jiang H and Fisher PB: Use of a sensitive and efficient subtraction hybridisation protocol for the identification of genes differentially regulated during induction of differentiation in human melanoma cells. Mol Cell Different 1: 285-299, 1993.
58. Wistrom C and Villeponteau B: Cloning and expression of SAG: a novel marker of cellular senescence. Exp Cell Res 199: 355-362, 1992.
59. Wadhwa R, Kaul SC, Sugimoto Y and Mitsui Y: Induction of cellular senescence by transfection of cytosolic mortalin cDNA in NIH 3T3 cells. J Biol Chem 268: 22239-22242, 1993.
60. Cowled PA, Ciccarelli C, Coccia E, Philipson L and Sorrentino V: Expression of growth arrest-specific (gas) genes in senescent cells. Exp Cell Res 211: 197-202, 1994.
61. Linskens MHK, Feng J, Andrews WH, Enlow BE, Saati SM, Tonkin LA, Funk WD and Villeponteau B: Cataloging altered gene expression in young and senescent cells using enhanced differential display. Nucl Acid Res 23: 3244-3251, 1995.
62. Atadja PW, Stringer KF and Riabowol KT: Loss of serum responce element binding activity and hyperphosphorylation of serum responce factor during cellular ageing. Mol Cell Biol 14: 4991-4999, 1994.
63. Dimri GP and Campisi J: Altered profile of transcription factor-binding activities in senescent human fibroblasts. Exp Cell Res 212: 132-140, 1994.
64. Bowlus CL, Mc Quillan JJ and Dean DC: Characterisation of three different elements in the 5′-flanking region of the fibronectin gene which mediate a transcriptional responce to cAMP. J Biol Chem 266: 1122-1127, 1991.
65. Rattan SIS: Cellular and molecular basis of aging. In: Hormones and Aging. (Eds P. S. Timiras, W. D. Quay and A. Vernadakis) Boca Raton, CRC Press, 1995, pp267-290.
66. Van Remmen H, Ward WF, Sabia RV and Richardson A: Gene expression and protein degradation. In: Handbook of Physiology: Aging (E. Masoro, ed.). Oxford University Press, 1995, pp171-234.
67. Wang E and Tomaszewski G: Granular presence of terminin is the marker to distinguish between the senescent and quiescent states. J Cell Physiol 147: 514-522, 1991.
68. Mc Clung JK, King RL, Walker LS, Danner DB, Nuell MJ, Stewart CA and Dell' Orco RT: Expression of prohibitin, an antiproliferative protein. Exp Gerontol 27: 413-417, 1992.
69. Cristofalo VJ, Pignolo RJ, Cianciarulo FL, Dipaolo BR and Rotenberg MO: Changes in gene expression during senescence in culture. Exp Gerontol 27: 429-432, 1992.
70. Di Paolo BR, Pignolo RJ and Cristofalo VJ: Identification of proteins differentially expressed in quiescent and proliferative senescent fibroblast cultures. Exp Cell Res 220: 178-185, 1995.
71. Marshall CJ: Tumour suppressor genes. Cell 64: 303-312, 1991.
72. Gonos ES and Spandidos DA: The retinoblastoma and p53 oncosuppressor genes and their role in human cancer. Cancer Mol Biol 1: 27-34, 1994.
73. Ferluga J: Potential role of anti-oncogenes in ageing. Mech Ageing Dev 53: 267-275, 1990.
74. Weinberg RA: The retinoblastoma gene and gene product. Cancer Surveys 12: 43-57, 1992.
75. Huang HJS, Yec JK, Shew JY, Chen PL, Bookstein R, Friedmann T, Lee EYHP and Lee WH: Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563-1566, 1988.
76. Bookstein R, Shew JY, Chen PL, Scully P and Lee WH: Suppression of tumorigenecity of human prostate carcinoma cells by replacing a mutant RB gene. Science 247: 712-715, 1990.
77. Muncaster MM, Cohen BL, Phillips RA and Callie BL: Failure of RB-1 to reverse the malignant phenotype of human tumor cell lines. Cancer Res 52: 654-661, 1992.
78. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
79. Stein GH, Beeson M and Gordon L: Failure to phosphorylate the RB gene product in senescent human fibroblasts. Science 240: 666-669, 1990.
80. La Thangue NB: DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control. Trends Biochem Sci 19: 108-114, 1994.
81. Chellapan SP, Hiebert S, Mudryi M, Horowitz JM and Nevins JR: The E2F transcription factor is a cellular target for the RB protein. Cell 65: 1053-1061, 1991.
82. Hollstcin M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991.
83. Bartek I, Bartkova S, Vojtesek B and Taylor-Papadimitriou J: Aberrant expression of the p53 onco-protein is common feature of a wide spectrum of human malignancies. Oncogene 6: 1699-1703, 1991.
84. Bond JA, Wyllie FS and Wyndford-Thomas D: Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9: 1885-1889, 1994.
85. Chen PL, Chen Y, Bookstein R and Lee WH: Genetic mechanisms of tumour suppression by the human p53 gene. Science 250: 1576-1580, 1990.
86. cdc2 in transformed cells. EMBO J 9: 2885-2889, 1990.
87. Xiong Y, Hannon GJ, Zhang H, Casso D, Kohayasi R and Beach D: p21 is a universal inhibitor of cyclin kinascs. Nature 366: 701-704, 1993.
88. Waga S, Hannon GJ, Beach D and Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578, 1994.
89. 53-independent mechanism. Proc Natl Acad Sci USA 92: 5545-5549, 1995.
90. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E and Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expresion in the absence of p53. Oncogene 9: 3397-3406, 1994.
91. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and El Houseini ME: Induction of p21 during differentiation. Oncogene 9: 3389-3396, 1994.
92. ciP1 in muscle and other terminally differentiated cells. Science 267: 1024-1027, 1995.
93. Jiang H, Lin S, Su ZZ, Kerbel RS, Herlyn M, Weissman RB, Welch DR and Fisher PB: The melanoma differentiation associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma. Oncogene 10: 1855-1864, 1995.
94. El Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer E, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumour suppression. Cell 75: 817-825, 1993.
95. sdi1 antisense RNA. Proc Natl Acad Sci USA 92: 4352-4356, 1995.
96. Zhan Q, Lord KA, Alamo I, Hollander C, Carrier F, Ron D, Kohn KW, Hofman B, Liebermann DA and Fornace AJ: The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth. Mol Cell Biol 14: 2361-2371, 1994.
97. Kamb A: Cell-cycle regulators and cancer. TIBS 11: 136-140, 1995.
98. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cdk4 inhibitor gene in mutiple human cancers. Nature 368: 753-755, 1994.
99. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG and Xiong Y: Growth suppression by p18, a p16 and p14 related cdk6 inhibitor, correlates with pRB function. Genes Devel 8: 2939-2952, 1994.
100. Okamoto K, and Beach D: Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J 13: 4816-4822, 1994.
101. Hannon G and Beach D: p15(ink4B) is a potential effector of TGF-b which induces cell cycle arrest. Nature 371: 257-261, 1994.
102. 1 cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74, 1994.
103. Lee M, Rynisdottir I and Massague J: Cloning of p57(kip2), a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Devel 9: 639-649, 1995.
104. Richter KH, Afshari CA, Annab LA, Burkhart BA, Owen RD, Boyd J and Barrett C: Down-regulation of cdc2 in senescent human and hamster cells. Cancer Res 51: 6010-6013, 1991.
105. Stein GH, Drullinger LF, Robetorye RS, Pereira-Smith OM and Smith JR: Senescent cells fail to express cdc2, cyc A, and cyc B in response to mitogen stimulation. Proc Natl Acad Sci U.S.A. 88: 11012-11016, 1991.
106. Tsuji Y, Ninomiya-Tsuji J, Tortim SV and Torti FM: Selective loss of CDC2 and CDK2 induction by tumor necrosis factor-a in senescent human diploid fibroblasts. Exp Cell Res 209: 175-182, 1993.
107. 1/S cell cycle mediators in cellular sesescence. Exp Cell Res 209: 231-237, 1993.
108. Gonos ES and Spandidos DA: The role of cdc2, cdc25 and cyclin A genes in the maintenance of immortalisation and growth arrest in a rat embryonic fibroblast conditional cell line. Cell Biol Int in press, 1996.
109. Rattan SIS: Gerontogenes: real or virtual? FASEB J 9: 284-286, 1995.
110. Murray AW and Kirschner MW: Dominoes and clocks: the union of two views of the cell cycle. Science 246: 614-621, 1989.
111. Wright WE, Pereira-Smith OM and Shay J: Reversible cellular senescence: implications for immortalisation of normal human diploid fibroblasts. Mol Cell Biol 9: 3088-3092, 1989.
112. Wright WE and Shay JW: The two-stage mechanism controlling cellular senescence and immortalisation. Exp Gerontol 27: 383-389, 1992.
113. Shay JW, Pereira-Smith OM and Wright WE: A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33-34, 1991.
114. Levy MZ, Allsopp RC, Futcher AB, Greider CW and Harley CB: Telomere end replication problem and cell ageing. J Mol Biol 225: 951-960, 1992.
115. Harley CB, Vaziri H, Counter CM and Allsopp RC: The telomere hypothesis of cellular ageing. Exp Gerontol 27: 375-382, 1992.
116. Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC, Stein CA, Nichols G, Khaled Z, Telang NT and Narayanan R: Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92: 12343-12346, 1995.
117. Wright WE, Brasiskyte D, Piatyszek MA and Shay JW: Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids. EMBO J 15: 1734-1741, 1996.
118. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015, 1994.
119. Klingelhutz A, Foster SA and McDougall JK: Telomerase activation by the E6 gene product of human papilloma virus type 16. Nature 380: 79-81, 1996.
120. Counter CM, Avilion AA, Le Feuvre CE, Stewart NG, Greider CW, Harley CB and Bacchetti S: Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 11: 1921-1929, 1992.